{{Rsnum
|rsid=1838149
|Gene=E2F3P1
|Chromosome=17
|position=35492283
|Orientation=minus
|GMAF=0.3173
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 35.4 | 46.2 | 18.5
| HCB | 86.7 | 13.3 | 0.0
| JPT | 84.1 | 15.9 | 0.0
| YRI | 44.4 | 36.5 | 19.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 86.7 | 13.3 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23720677
|Title=Genetic variants in pseudogene E2F3P1 confer risk for HBV-related hepatocellular carcinoma in a Chinese population
|OA=1
}}{{PMID Auto
|PMID=20045101
|Title=Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control.
|OA=1
}}